Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis Toxina botulínica tipo A para o tratamento da espasticidade de membros superiores pós-AVC: metanálise

Muscle over-activity is one of the cardinal features of spasticity and it is a common disability of stroke patients. In this group, spasticity is responsible for several limitations that interfere in their daily activities and quality of life. To treat spasticity, neurologists usually prescribe drug...

Full description

Bibliographic Details
Main Authors: Eduardo Cardoso, Bernardo Rodrigues, Rita Lucena, Irismar Reis de Oliveira, Glícia Pedreira, Ailton Melo
Format: Article
Language:English
Published: Academia Brasileira de Neurologia (ABNEURO) 2005-03-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
AVC
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2005000100006